Gary Bassell

Dr. Gary Bassell

Emory University, Atlanta, Georgia, USA
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2021 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
YKYunhee Kang
Yunhee Kang
YZYing Zhou
Ying Zhou
YLYujing Li
Yujing Li
YHYanfei Han
Yanfei Han
JXJie Xu
Jie Xu
ZWZhexing Wen
Zhexing Wen

27 July 2011 in Neuropsychopharmacology
Verified
Journal Article
Closed access
CGChristina Gross
Christina Gross
EBElizabeth M Berry-Kravis
Elizabeth M Berry-Kravis
Gary BassellGary Bassell
Gary Bassell

1 August 2018 in Brain Research
Verified
Journal Article
Open access
ABAnwesha Banerjee
Anwesha Banerjee
MIMarius F. Ifrim
Marius F. Ifrim
AVArielle Nicole Valdez-Sinon
Arielle Nicole Valdez-Sinon
NRNisha Raj
Nisha Raj
Gary BassellGary Bassell
Gary Bassell
Research in the past decades has unfolded the multifaceted role of Fragile X mental retardation protein (FMRP) and how its absence contributes to the pathophysiology of Fragile X syndrome (FXS). Excess signaling through group 1 metabotropic glutamate receptors is commonly observed in mouse models of FXS, which in part is attributed to dysregulated translation and downstream signaling. Considering the wide spectrum of cellular and physiologic functions that loss of FMRP can affect in general, it may be advantageous to pursue disease mechanism based treatments that directly target translational components or signaling factors that regulate protein synthesis. Various FMRP targets upstream and downstream of the translational machinery are therefore being investigated to further our understanding of the molecular mechanism of RNA and protein synthesis dysregulation in FXS as well as test their potential role as therapeutic interventions to alleviate FXS associated symptoms. In this review, we will broadly discuss recent advancements made towards understanding the role of FMRP in translation regulation, new pre-clinical animal models with FMRP targets located at different levels of the translational and signal transduction pathways for therapeutic intervention as well as future use of stem cells to model FXS associated phenotypes.

7 October 2011 in Molecular Brain
Verified
Journal Article
Open access
PDF file
SSSharon Swanger
Sharon Swanger
XYXiaodi Yao
Xiaodi Yao
CGChristina Gross
Christina Gross
Gary BassellGary Bassell
Gary Bassell
Uncovering the mechanisms that regulate dendritic spine morphology has been limited, in part, by the lack of efficient and unbiased methods for analyzing spines. Here, we describe an automated 3D spine morphometry method and its application to spine remodeling in live neurons and spine abnormalities in a disease model. We anticipate that this approach will advance studies of synapse structure and function in brain development, plasticity, and disease.

6 May 2015 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
MIMarius F. Ifrim
Marius F. Ifrim
KWKathryn R. Williams
Kathryn R. Williams
Gary BassellGary Bassell
Gary Bassell
Fragile X syndrome (FXS) is caused by the loss of the fragile X mental retardation protein (FMRP), an RNA binding protein that regulates translation of numerous target mRNAs, some of which are dendritically localized. Our previous biochemical studies using synaptoneurosomes demonstrate a role for FMRP and miR-125a in regulating the translation of PSD-95 mRNA. However, the local translation of PSD-95 mRNA within dendrites and spines, as well as the roles of FMRP or miR-125a, have not been directly studied. Herein, local synthesis of a Venus-PSD-95 fusion protein was directly visualized in dendrites and spines using single-molecule imaging of a diffusion-restricted Venus-PSD-95 reporter under control of the PSD-95 3′UTR. The basal translation rates of Venus-PSD-95 mRNA was increased in cultured hippocampal neurons fromFmr1KO mice compared with WT neurons, which correlated with a transient elevation of endogenous PSD-95 within dendrites. Following mGluR stimulation with (S)-3,5-dihydroxyphenylglycine, the rate of Venus-PSD-95 mRNA translation increased rapidly in dendrites of WT hippocampal neurons, but not in those ofFmr1KO neurons or when the binding site of miR125a, previously shown to bind PSD-95 3′UTR, was mutated. This study provides direct support for the hypothesis that local translation within dendrites and spines is dysregulated in FXS. Impairments in the regulated local synthesis of PSD-95, a critical regulator of synaptic structure and function, may affect the spatiotemporal control of PSD-95 levels and affect dendritic spine development and synaptic plasticity in FXS.

15 May 2013 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
SSSharon Swanger
Sharon Swanger
YHYuncen A. He
Yuncen A. He
JRJoel D. Richter
Joel D. Richter
Gary BassellGary Bassell
Gary Bassell
Long-term synaptic plasticity involves changes in the expression and membrane insertion of cell-surface proteins. Interestingly, the mRNAs encoding many cell-surface proteins are localized to dendrites, but whether dendritic protein synthesis is required for activity-induced surface expression of specific proteins is unknown. Herein, we used microfluidic devices to demonstrate that dendritic protein synthesis is necessary for activity-induced insertion of GluN2A-containing NMDA receptors in rat hippocampal neurons. Furthermore, visualization of activity-induced local translation of GluN2A mRNA and membrane insertion of GluN2A protein in dendrites was directly observed and shown to depend on a 3′ untranslated region cytoplasmic polyadenylation element and its associated translation complex. These findings uncover a novel mechanism for cytoplasmic polyadenylation element-mediated posttranscriptional regulation of GluN2A mRNA to control NMDA receptor surface expression during synaptic plasticity.